Shanghai Allist Pharmaceuticals Co., Ltd. (SHA:688578)

SHA:688578 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	51,899	26,955	18,747	8,856	13,590	12,816
Market Cap Growth	83.56%	43.78%	111.69%	-34.83%	6.04%	-
Enterprise Value	48,254	23,927	16,494	6,916	11,015	12,083
Last Close Price	115.33	59.66	40.98	19.36	29.71	28.02
PE Ratio	33.82	18.85	29.10	67.85	743.66	-
Forward PE	28.34	83.59	83.59	74.26	109.82	-
PS Ratio	13.26	7.58	9.29	11.20	25.64	22849.52
PB Ratio	9.21	5.10	4.71	2.78	4.57	4.45
P/TBV Ratio	9.31	5.17	4.79	2.84	4.68	4.56
P/FCF Ratio	39.55	20.80	30.90	-	-	-
P/OCF Ratio	32.57	17.21	27.79	96.65	463.96	-
EV/Sales Ratio	12.33	6.73	8.17	8.74	20.78	21543.30
EV/EBITDA Ratio	28.82	15.83	28.12	117.62	-	-
EV/EBIT Ratio	29.49	16.22	30.01	179.00	-	-
EV/FCF Ratio	36.77	18.47	27.18	-	-	-
Debt / Equity Ratio	0.00	0	0	0.00	0.00	-
Debt / EBITDA Ratio	0.00	0.00	0.00	0.03	-	-
Debt / FCF Ratio	0.00	0.00	0.00	-	-	-
Asset Turnover	0.72	0.69	0.52	0.24	0.17	0
Inventory Turnover	4.52	3.62	2.32	1.78	1.90	0.03
Quick Ratio	6.99	6.73	7.18	8.62	14.59	23.80
Current Ratio	7.80	6.96	7.46	8.98	15.21	24.58
Return on Equity (ROE)	30.81%	30.86%	17.97%	4.24%	0.63%	-15.29%
Return on Assets (ROA)	18.70%	17.92%	8.79%	0.73%	-1.43%	-10.48%
Return on Capital (ROIC)	20.53%	19.90%	9.58%	0.78%	-1.49%	-10.84%
Return on Capital Employed (ROCE)	28.90%	27.80%	13.80%	1.20%	-	-
Earnings Yield	2.96%	5.30%	3.44%	1.47%	0.13%	-2.42%
FCF Yield	2.53%	4.81%	3.24%	-0.59%	-1.20%	-2.23%
Dividend Yield	0.68%	1.09%	0.98%	-	-	-
Payout Ratio	19.06%	20.46%	-	-	-	-
Buyback Yield / Dilution	0.91%	0.18%	-0.09%	1.49%	-23.59%	-2.30%
Total Shareholder Return	1.59%	1.27%	0.89%	1.49%	-23.59%	-2.30%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.